Press Releases

Forge Therapeutics receives notice of allowance from U.S. patent and trademark office covering novel chemistry targeting LpxC for the treatment of gram-negative bacterial infections

-Issuance of patent demonstrates utility of Forge’s BLACKSMITH chemistry platform- San Diego, California, Aug 14, 2019 – Forge Therapeutics, Inc. (Forge), a ...

Forge Therapeutics receives notice of allowance from U.S. patent and trademark office covering novel chemistry targeting LpxC for the treatment of gram-negative bacterial infections2020-03-03T10:53:03-08:00

Forge announces oral presentation on development of novel antibiotics at the 28th annual ECCMID meeting

San Diego, California, April 9, 2018 – Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, today announced that David ...

Forge announces oral presentation on development of novel antibiotics at the 28th annual ECCMID meeting2018-04-09T06:55:22-07:00

Forge Therapeutics to Present at the 2018 Needham & Company Healthcare Conference

-Presentation will focus on Forge’s portfolio of four novel classes of antibiotics to treat deadly ‘superbug’ infections from Gram-negative bacteria- San Diego, California, ...

Forge Therapeutics to Present at the 2018 Needham & Company Healthcare Conference2018-03-21T09:31:14-07:00
Load More Posts
Go to Top